Louisiana 2024 Regular Session

Louisiana House Bill HB508

Introduced
3/1/24  
Introduced
3/1/24  
Refer
3/1/24  
Refer
3/1/24  
Refer
3/11/24  
Refer
3/11/24  
Report Pass
4/9/24  
Report Pass
4/9/24  
Engrossed
4/16/24  
Engrossed
4/16/24  
Refer
4/17/24  
Refer
4/17/24  
Report Pass
4/24/24  
Report Pass
4/24/24  
Refer
4/29/24  
Refer
4/29/24  
Report Pass
5/13/24  
Report Pass
5/13/24  
Enrolled
5/30/24  
Enrolled
5/30/24  
Chaptered
6/11/24  
Chaptered
6/11/24  
Passed
6/11/24  

Caption

Provides relative to medical and surgical treatments of cancer (EN SEE FISC NOTE SG EX)

Impact

The bill will have a significant impact on state health laws by mandating that all health benefit plans covering medical and surgical treatments for cancer must also cover treatments for any resulting urinary or sexual dysfunction. This mandate reflects a broader push within the healthcare community to not only treat the primary illness but also address side effects distinctly affecting the quality of life. Additionally, the bill clarifies definitions related to health insurance plans, expanding the scope of coverage for patients and standardizing requirements across different providers.

Summary

House Bill 508 aims to enhance health insurance coverage for patients diagnosed with cancer by ensuring that patients can choose their medical and surgical treatments. This bill stipulates that treatment decisions shall be made solely between the patient and their attending physician, thereby emphasizing patient autonomy and informed choice when it comes to managing their cancer care. The legislation aims to ensure that insurance coverage includes medically necessary treatments related to cancer, as defined in the bill, without restrictions that may have previously existed.

Sentiment

Overall, the sentiment surrounding HB 508 appears to be positive, with strong support from patient advocacy groups, healthcare professionals, and legislators who prioritize patient choice and comprehensive care. The bill is seen as a progressive step towards acknowledging the complexities of cancer treatment and its ramifications, aligning with contemporary medical standards and patient-centered care protocols. Stakeholders argue that this bill could pilot improvements in patient satisfaction and health outcomes by providing tailored treatment options.

Contention

While the bill has garnered a majority of support, certain concerns have emerged regarding its implementation and the potential financial implications for health insurance providers. Opponents argue that mandating increased coverage could lead to higher premiums and limit choices in terms of insurance products available in the market. Additionally, there are discussions about the degree to which the definitions and provisions in the bill align with existing health insurance regulations and whether they could lead to complications in coverage administration.

Companion Bills

No companion bills found.

Previously Filed As

LA HB766

Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)

LA HB4070

Relating to health care; and prescribing an effective date.

LA S09230

Provides hospital, surgical and medical insurance coverage for perimenopausal and menopausal care and treatment.

LA A05444

Provides hospital, surgical and medical insurance coverage for perimenopausal and menopausal care and treatment.

LA HB1199

Provides relative to health insurance coverage for genetic testing and the treatment of SCN2A-associated medical conditions (EN NO IMPACT See Note)

LA HB357

Requires health insurance coverage for integrative cancer treatments (EN INCREASE GF EX See Note)

LA HB1418

Medicaid; provide for reimbursement for vagus nerve stimulation (VNS) surgical implant procedures.

LA A3043

Requires medical fee schedule by automobile insurers to provide for reimbursement of certain services provided by ambulatory surgical center at rate of 300 percent of Medicare payment rate.

LA A2281

Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

LA S3006

Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

Similar Bills

WI AB925

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

AZ HB2944

Inpatient treatment days; computation; exclusion

CA AB1879

Substance use: treatment or residential data reporting.

WI SB904

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

CA AB2538

Medi-Cal: hospice providers: forms.

AZ SB1244

court-ordered treatment; continuation

IA HF518

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)

IA HF326

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)